(Q45139842)

9 December 2017

title

Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals (English)

1 reference

9 December 2017

M Sanchez

1

1 reference

9 December 2017

N Picard

series ordinal

2

1 reference

9 December 2017

K Sauvé

series ordinal

3

1 reference

9 December 2017

A Tremblay

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

20 February 2012

1 reference

9 December 2017

1 reference

9 December 2017

volume

32

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

117-126

1 reference

Estrogen receptors: how do they signal and what are their targets

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Steroid receptor phosphorylation: a key modulator of multiple receptor functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Challenging estrogen receptor beta with phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

The hormonal response of estrogen receptor beta is decreased by the phosphatidylinositol 3-kinase/Akt pathway via a phosphorylation-dependent release of CREB-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

CBP and p300: HATs for different occasions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Proteasome-dependent degradation of the human estrogen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Coactivator AIB1 links estrogen receptor transcriptional activity and stability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Mdm2-mediated ubiquitylation: p53 and beyond.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Selective estrogen-receptor modulators and antihormonal resistance in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Estrogen receptor-beta status influences clinical outcome of triple-negative breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Prostate cancer: beta control your hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Expression of estrogen receptors alpha and beta in early steps of human breast carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

ER beta inhibits proliferation and invasion of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.19

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.19

1 reference

Dimensions Publication ID

9 December 2017

1029393004

0 references

1 reference